Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$163.6 - $209.11 $6.34 Million - $8.11 Million
38,761 New
38,761 $6.64 Million
Q2 2022

Aug 15, 2022

SELL
$186.4 - $279.02 $143,714 - $215,124
-771 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$194.8 - $275.7 $570,374 - $807,249
-2,928 Reduced 79.16%
771 $205,000
Q4 2021

Feb 14, 2022

BUY
$255.32 - $318.29 $944,428 - $1.18 Million
3,699 New
3,699 $984,000
Q3 2021

Nov 15, 2021

SELL
$260.36 - $307.27 $1.93 Million - $2.28 Million
-7,405 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$225.52 - $304.06 $1.67 Million - $2.25 Million
7,405 New
7,405 $2.03 Million
Q1 2021

May 17, 2021

SELL
$235.95 - $293.05 $1.94 Million - $2.4 Million
-8,204 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$215.97 - $265.89 $701,038 - $863,078
3,246 Added 65.47%
8,204 $2.1 Million
Q3 2020

Nov 16, 2020

SELL
$192.55 - $236.59 $534,711 - $657,010
-2,777 Reduced 35.9%
4,958 $1.17 Million
Q2 2020

Aug 14, 2020

BUY
$159.17 - $224.73 $1.23 Million - $1.74 Million
7,735 New
7,735 $1.5 Million
Q1 2020

May 15, 2020

SELL
$130.01 - $216.44 $48,103 - $80,082
-370 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$144.81 - $186.0 $53,579 - $68,820
370 New
370 $63,000
Q3 2019

Nov 14, 2019

SELL
$117.35 - $167.95 $273,660 - $391,659
-2,332 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$82.13 - $120.73 $191,527 - $281,542
2,332 New
2,332 $278,000
Q1 2019

May 15, 2019

SELL
$72.44 - $101.87 $217 - $305
-3 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$73.27 - $105.19 $219 - $315
3 New
3 $0
Q3 2018

Nov 14, 2018

SELL
$81.43 - $108.13 $18,484 - $24,545
-227 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$83.27 - $101.93 $18,902 - $23,138
227 New
227 $19,000
Q1 2018

May 15, 2018

SELL
$68.49 - $87.2 $753 - $959
-11 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$55.67 - $71.8 $612 - $789
11
11 $1,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $19.4B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.